Quantiva In Paris
By Quantiva Team
VivaTech: Europe's Largest Startup Conference
Quantiva's team traveled to Paris to participate in VivaTech, Europe's largest startup conference. The visit focused on meeting innovative early-stage companies and understanding market challenges.
US Market Entry Challenges
A dominant topic among European founders involved breaking into the American market. Companies developing SaMD (Software as a Medical Device) products with AI/ML components face particular obstacles. Founders expressed concern about the considerable effort and cost required to obtain the required FDA 510(k) clearance, which can be prohibitive for early stage companies.
Digital Twin Applications
While digital twins are established in manufacturing and supply chains, their emerging use in medtech and biotech ventures proved particularly notable at the conference.
Featured Companies
DeepLife — Creates cellular-level digital twins supporting drug discovery by simulating molecular effects before physical experimentation.
inHEART — Develops patient heart digital twins enabling surgeons to visualize anatomy and plan procedures more efficiently.
.lumen — Produces assistive glasses using haptic feedback to help visually impaired users navigate environments. The company later showcased at NVIDIA GTC in San Jose.
The Takeaway
Despite industry hype around AI, we found genuine innovation among attendees. Many founders appreciated Quantiva's expertise in navigating US deployment and achieving authentic AI advancement.